Cooper Companies logo
Cooper Companies
COO | NASDAQ
Chart Builder DCF Calculator
$61.88
-$0.77 (-1.23%)
At close: Nov 16, 2026, 4:00 PM ET
$61.88
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Cooper Companies Company Profile

Company profile explained

Company Profile

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Key Executives

Name Position
Albert G. White President, Chief Executive Officer & Non-Independent Director
Brian G. Andrews Executive VP, CFO & Principal Accounting Officer
Daniel G. McBride Executive VP, COO General Counsel & Secretary
Gerard H. Warner President of CooperVision, Inc.
Holly R. Sheffield President of CooperSurgical, Inc.
Kim Duncan Vice President of Investor Relations & Risk Management

Latest SEC Filings

Date Type Title
Oct 27, 2026 8-K Current Report
Sep 17, 2026 4 Filing
Sep 15, 2026 4 Filing
Sep 15, 2026 4 Filing
Sep 15, 2026 4 Filing
Sep 09, 2026 10-Q Quarterly Report
Sep 09, 2026 8-K Current Report
Jul 06, 2026 4 Filing
Jul 06, 2026 3 Filing
Jun 05, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Cooper Companies
Cooper Companies logo
Country United States
IPO Date Jan 21, 1983
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 15,000
CEO Albert G. White

Contact Details

6101 Bollinger Canyon Road San Ramon, California 94583 United States

Stock Details

Ticker Symbol COO
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
CIK Code 0000711404
CUSIP Number 216648501
ISIN Number US2166485019
SIC Code 3851

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.